Literature DB >> 31755876

Increase in detection of Corynebacterium diphtheriae in Canada: 2006-2019.

K A Bernard1,2, A L Pacheco1, T Burdz1, D Wiebe1.   

Abstract

BACKGROUND: Increasingly, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) has been used to provide rapid, inexpensive and precise identification of bacteria, including Corynebacterium species. Only three Corynebacterium species are able to produce diphtheria toxin (DT), and strains recovered may be either toxin-producing or non-toxin-producing. It appears the more precise bacterial identification provided by MALDI-TOF systems has led to an increase in requests submitted to the National Microbiology Laboratory (NML) for toxin testing.
OBJECTIVE: To describe the number of isolates identified as C. diphtheriae, C. ulcerans and C. pseudotuberculosis, submitted to the NML between January 2006 and July 30, 2019, including their geographic area, source, and whether they produce DT.
METHODS: Referrals to the NML of human or animal isolates that were identified as any of those three Corynebacterium species were studied with respect to province, source and toxigenicity. Species identification was confirmed and then specimens were tested by polymerase chain reaction for the presence of tox genes and, if positive, for expression of DT by the modified Elek method. Analysis was descriptive.
RESULTS: Over the study period, 639 isolates were identified as C. diphtheriae, 22 isolates as C. ulcerans; no isolates were identified as C. pseudotuberculosis. There was an increase in C. diphtheriae referrals for DT testing: from eight per year in 2006 to an average of 15 per month in 2019, or a 1,200% increase over the 13.6-year period. The referrals were primarily from western Canada (n=609/639; 95%). Most (638/639, 99%) were human isolates and most were obtained from cutaneous sites. Of those isolates, 87/639 (13.6%) were found to be toxigenic and 552/639 (86.4%) non-toxigenic. Among C. ulcerans referrals, 17/22 (77%) were from humans and five (23%) were from animals, with 10/22 (45%) being toxigenic.
CONCLUSION: There has been a marked increase in referrals to the NML for DT testing of Corynebacterium species. This could be due to the enhanced ability to identify these bacteria using MALDI-TOF systems. Ongoing monitoring will help to assess whether the increase is due solely to increased precision of diagnosis or whether these are emerging cutaneous pathogens.

Entities:  

Keywords:  Corynebacterium diphtheriae; MALDI-TOF; diphtheria-toxin-producing species; increase in recovery

Year:  2019        PMID: 31755876      PMCID: PMC6850721          DOI: 10.14745/ccdr.v45i11a04

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  17 in total

1.  rpoB gene sequencing for identification of Corynebacterium species.

Authors:  Atieh Khamis; Didier Raoult; Bernard La Scola
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Public health action following an outbreak of toxigenic cutaneous diphtheria in an Auckland refugee resettlement centre.

Authors:  Gary E Reynolds; Helen Saunders; Angela Matson; Fiona O'Kane; Sally A Roberts; Salvin K Singh; Lesley M Voss; Tomasz Kiedrzynski
Journal:  Commun Dis Intell Q Rep       Date:  2016-12-24

Review 3.  Non-toxigenic penicillin-resistant cutaneous C. diphtheriae infection: a case report and review of the literature.

Authors:  Rosemarie Philippa FitzGerald; Andrew J Rosser; Dona Nelun Perera
Journal:  J Infect Public Health       Date:  2014-07-12       Impact factor: 3.718

4.  Cutaneous diphtheria in the urban poor population of Vancouver, British Columbia, Canada: a 10-year review.

Authors:  C F Lowe; K A Bernard; M G Romney
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

5.  Canada's first case of a multidrug-resistant Corynebacterium diphtheriae strain, isolated from a skin abscess.

Authors:  Neil V Mina; Tamara Burdz; Deborah Wiebe; Jagtar S Rai; Tazim Rahim; Fern Shing; Linda Hoang; Kathryn Bernard
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

6.  A modified Elek test for detection of toxigenic corynebacteria in the diagnostic laboratory.

Authors:  K H Engler; T Glushkevich; I K Mazurova; R C George; A Efstratiou
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

Review 7.  The genus corynebacterium and other medically relevant coryneform-like bacteria.

Authors:  Kathryn Bernard
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

8.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology.

Authors:  Robin Patel
Journal:  Clin Infect Dis       Date:  2013-04-17       Impact factor: 9.079

9.  Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing.

Authors:  D M Meinel; R Kuehl; R Zbinden; V Boskova; C Garzoni; D Fadini; M Dolina; B Blümel; T Weibel; S Tschudin-Sutter; A F Widmer; J A Bielicki; A Dierig; U Heininger; R Konrad; A Berger; V Hinic; D Goldenberger; A Blaich; T Stadler; M Battegay; A Sing; A Egli
Journal:  Clin Microbiol Infect       Date:  2016-08-30       Impact factor: 8.067

10.  Cutaneous Diphtheria Mimicking Pyoderma Gangrenosum.

Authors:  Daniel Morgado-Carrasco; Constanza Riquelme-Mc Loughlin; Xavier Fustá-Novell; Mariana J Fernández-Pittol; Jordi Bosch; José M Mascaró
Journal:  JAMA Dermatol       Date:  2018-02-01       Impact factor: 10.282

View more
  8 in total

1.  Detection and Characterization of Diphtheria Toxin Gene-Bearing Corynebacterium Species through a New Real-Time PCR Assay.

Authors:  Margaret M Williams; Jessica L Waller; Janessa S Aneke; Michael R Weigand; Maureen H Diaz; Katherine E Bowden; Ashley K Simon; Yanhui Peng; Lingzi Xiaoli; Pamela K Cassiday; Jonas Winchell; M Lucia Tondella
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

2.  Ten Years of Diphtheria Toxin Testing and Toxigenic Cutaneous Diphtheria Investigations in Alberta, Canada: A Highly Vaccinated Population.

Authors:  Natalie C Marshall; Maulik Baxi; Clayton MacDonald; Angela Jacobs; Christopher A Sikora; Gregory J Tyrrell
Journal:  Open Forum Infect Dis       Date:  2021-08-20       Impact factor: 3.835

3.  Describing the burden of diphtheria in Canada from 2006 to 2017, using hospital administrative data and reportable disease data.

Authors:  Dolly Lin; Brigitte Ho Mi Fane; Susan G Squires; Catherine Dickson
Journal:  Can Commun Dis Rep       Date:  2021-10-14

4.  Fatal respiratory diphtheria in a visitor to Canada.

Authors:  Scott Cholewa; Fareen Karachiwalla; Sarah E Wilson; Jeya Nadarajah; Julianne V Kus
Journal:  CMAJ       Date:  2021-01-04       Impact factor: 8.262

5. 

Authors:  Scott Cholewa; Fareen Karachiwalla; Sarah E Wilson; Jeya Nadarajah; Julianne V Kus
Journal:  CMAJ       Date:  2021-03-08       Impact factor: 8.262

6.  Cutaneous infection by non-diphtheria-toxin producing and penicillin-resistant Corynebacterium diphtheriae strain in a patient with diabetes mellitus.

Authors:  Max Roberto Batista Araújo; Mireille Ângela Bernardes Sousa; Luisa Ferreira Seabra; Letícia Aparecida Caldeira; Carmem Dolores Faria; Sérgio Bokermann; Lincoln Oliveira Sant'Anna; Louisy Sanches Dos Santos; Ana Luíza Mattos-Guaraldi
Journal:  Access Microbiol       Date:  2021-11-30

7.  Cutaneous diphtheria complicated oncologic reconstruction surgery in osteosarcoma.

Authors:  Babak Abdolkarimi; Ali Amanati; Gholamreza Bahoush Mehdiabadi
Journal:  Clin Case Rep       Date:  2022-02-10

8.  Application of loop-mediated isothermal amplification combined with colorimetric and lateral flow dipstick visualization as the potential point-of-care testing for Corynebacterium diphtheriae.

Authors:  Aleksandra A Zasada; Aldona Wiatrzyk; Urszula Czajka; Klaudia Brodzik; Kamila Formińska; Ewa Mosiej; Marta Prygiel; Katarzyna Krysztopa-Grzybowska; Karol Wdowiak
Journal:  BMC Infect Dis       Date:  2020-04-25       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.